Breaking News: Eurofins Genomics Secures $60 Million in Funding to Revolutionize Genomic Services Worldwide

Eurofins Genomics, a leading international provider of genomic services and a proud member of the Eurofins Scientific Group, has successfully raised €60 million in a significant funding round aimed at enhancing its state-of-the-art genomic services. Founded in 1990, Eurofins Genomics operates across a network of laboratories in 61 countries, employing a diverse team of 61,000 dedicated professionals. This latest capital infusion underscores the company’s commitment to advancing its core business offerings, which include next-generation sequencing, genotyping, gene expression analysis, and custom DNA sequencing, among others. With a strong focus on delivering tailored solutions for sectors such as pharmaceuticals, diagnostics, agriculture, food, biotechnology, and scientific research, Eurofins Genomics plans to utilize this funding to expand its technological capabilities and enhance customer service. Investments will be directed towards upgrading laboratory infrastructure and R&D initiatives to drive innovation and streamline processes, further strengthening the company’s position in the competitive life sciences market. Eurofins Genomics’ dedication to providing high-quality genomic services reflects its mission to support the advancement of research and technology in life sciences, thereby contributing to the betterment of global health and food safety. As the genomic landscape continues to evolve, Eurofins remains at the forefront of delivering solutions that meet the changing needs of its diverse clientele. Stay tuned as we embark on this exciting journey of growth and innovation, set to redefine the boundaries of genomic research and application. For more information, visit our website [here](https://www.eurofinsgenomics.eu/imprint/) and learn about our commitment to privacy [here](https://www.eurofinsgenomics.eu/privacy/).